Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation

Abstract

Perturbation of addition of second heart field (SHF) cardiac progenitor cells to the poles of the heart tube results in congenital heart defects (CHD). The transcriptional programs and upstream regulatory events operating in different subpopulations of the SHF remain unclear. Here, we profile the transcriptome and chromatin accessibility of anterior and posterior SHF sub-populations at genome-wide levels and demonstrate that Hoxb1 negatively regulates differentiation in the posterior SHF. Spatial mis-expression of Hoxb1 in the anterior SHF results in hypoplastic right ventricle. Activation of Hoxb1 in embryonic stem cells arrests cardiac differentiation, whereas Hoxb1-deficient mouse embryos display premature cardiac differentiation. Moreover, ectopic differentiation in the posterior SHF of embryos lacking both Hoxb1 and its paralog Hoxa1 results in atrioventricular septal defects. Our results show that Hoxb1 plays a key role in patterning cardiac progenitor cells that contribute to both cardiac poles and provide new insights into the pathogenesis of CHD.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2 and 3.

Article and author information

Author details

  1. Sonia Stefanovic

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Brigitte Laforest

    Department of Pediatrics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6919-8922
  3. Jean-Pierre Desvignes

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Fabienne Lescroart

    INSERM, MMG, U1251, Aix-Marseille Université, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4942-7921
  5. Laurent Argiro

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Corinne Maurel-Zaffran

    IBDM, CNRS-AMU, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  7. David Salgado

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Elise Plaindoux

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Christopher De Bono

    IBDM, CNRS UMR7288, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Kristijan Pazur

    Paul Langerhans Institute Dresden of Helmholtz Centre Munich, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Magali Théveniau-Ruissy

    INSERM U1251 Marseille Medical Genetics, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7346-7096
  12. Christophe Béroud

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Michel Puceat

    INSERM U1251 Marseille Medical Genetics, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9055-7563
  14. Anthony Gavalas

    Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Robert G Kelly

    CNRS UMR 7288, Aix-Marseille Université, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Stephane Zaffran

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    For correspondence
    stephane.zaffran@univ-amu.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0811-418X

Funding

Agence Nationale de la Recherche (ANR-13-BSV2-0003)

  • Michel Puceat
  • Robert G Kelly
  • Stephane Zaffran

Agence Nationale de la Recherche (ANR-18-CE13-0011)

  • Robert G Kelly
  • Stephane Zaffran

Fondation Lefoulon Delalande

  • Sonia Stefanovic
  • Fabienne Lescroart

Association Française contre les Myopathies (MNH-Decrypt)

  • Stephane Zaffran

Fondation pour la Recherche Médicale

  • Brigitte Laforest

Fondation pour la Recherche Médicale (DEQ20150331717)

  • Robert G Kelly

European Commission (H2020-MSCA-IF-2014)

  • Sonia Stefanovic

Fondation Leducq (Research Equipment and Technological Platform Awards)

  • Michel Puceat
  • Robert G Kelly
  • Stephane Zaffran

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Richard P Harvey, Victor Chang Cardiac Research Institute, Australia

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal procedures were carried out under protocols approved by a national appointed ethical committee for animal experimentation (Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche; Authorization N{degree sign}32-08102012).

Version history

  1. Received: January 13, 2020
  2. Accepted: August 16, 2020
  3. Accepted Manuscript published: August 17, 2020 (version 1)
  4. Version of Record published: September 1, 2020 (version 2)

Copyright

© 2020, Stefanovic et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,758
    views
  • 366
    downloads
  • 39
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sonia Stefanovic
  2. Brigitte Laforest
  3. Jean-Pierre Desvignes
  4. Fabienne Lescroart
  5. Laurent Argiro
  6. Corinne Maurel-Zaffran
  7. David Salgado
  8. Elise Plaindoux
  9. Christopher De Bono
  10. Kristijan Pazur
  11. Magali Théveniau-Ruissy
  12. Christophe Béroud
  13. Michel Puceat
  14. Anthony Gavalas
  15. Robert G Kelly
  16. Stephane Zaffran
(2020)
Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation
eLife 9:e55124.
https://doi.org/10.7554/eLife.55124

Share this article

https://doi.org/10.7554/eLife.55124

Further reading

    1. Developmental Biology
    2. Medicine
    Stephen E Flaherty III, Olivier Bezy ... Zhidan Wu
    Research Article

    From a forward mutagenetic screen to discover mutations associated with obesity, we identified mutations in the Spag7 gene linked to metabolic dysfunction in mice. Here, we show that SPAG7 KO mice are born smaller and develop obesity and glucose intolerance in adulthood. This obesity does not stem from hyperphagia, but a decrease in energy expenditure. The KO animals also display reduced exercise tolerance and muscle function due to impaired mitochondrial function. Furthermore, SPAG7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental insufficiency, likely due to abnormal development of the placental junctional zone. This insufficiency leads to loss of SPAG7-deficient fetuses in utero and reduced birth weights of those that survive. We hypothesize that a ‘thrifty phenotype’ is ingrained in SPAG7 KO animals during development that leads to adult obesity. Collectively, these results indicate that SPAG7 is essential for embryonic development and energy homeostasis later in life.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Nikola Sekulovski, Jenna C Wettstein ... Kenichiro Taniguchi
    Research Article

    Amniogenesis, a process critical for continuation of healthy pregnancy, is triggered in a collection of pluripotent epiblast cells as the human embryo implants. Previous studies have established that bone morphogenetic protein (BMP) signaling is a major driver of this lineage specifying process, but the downstream BMP-dependent transcriptional networks that lead to successful amniogenesis remain to be identified. This is, in part, due to the current lack of a robust and reproducible model system that enables mechanistic investigations exclusively into amniogenesis. Here, we developed an improved model of early amnion specification, using a human pluripotent stem cell-based platform in which the activation of BMP signaling is controlled and synchronous. Uniform amniogenesis is seen within 48 hr after BMP activation, and the resulting cells share transcriptomic characteristics with amnion cells of a gastrulating human embryo. Using detailed time-course transcriptomic analyses, we established a previously uncharacterized BMP-dependent amniotic transcriptional cascade, and identified markers that represent five distinct stages of amnion fate specification; the expression of selected markers was validated in early post-implantation macaque embryos. Moreover, a cohort of factors that could potentially control specific stages of amniogenesis was identified, including the transcription factor TFAP2A. Functionally, we determined that, once amniogenesis is triggered by the BMP pathway, TFAP2A controls the progression of amniogenesis. This work presents a temporally resolved transcriptomic resource for several previously uncharacterized amniogenesis states and demonstrates a critical intermediate role for TFAP2A during amnion fate specification.